Flow Pharma's Convertible Note Round

Flow Pharma raised a round of funding on March 22, 2016.

Flow Pharma is developing FlowVax HPV to treat cervical cancer, using computational modeling and AI deep learning to design synthetic, CTL Immuno-Oncology therapeutics.…

Articles about Flow Pharma's Convertible Note Round: